Riskpilot← Back to searchSign inGet full accessCarryGenes Management AB
ABActiveOrg 5592430168Rörstrandsgatan 58All other professional, scientific and technical activities n.e.c. · NACE 7499Est. 20201 employees
Revenue 2024
SEK 0
EBITDA margin
—
+87% vs 2023
Equity ratio
1.0%
Financial strength
Net profit 2024
SEK -2,8M
-16% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -412K | +87% |
| Net profit | SEK -2,8M | -16% |
| Total assets | SEK 2,5M | -12% |
| Equity | SEK 25K | -93% |
| Employees | 1 | — |
Legal name
CarryGenes Management AB
Org number
5592430168
Legal form
Aktiebolag
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
18 februari 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas ensam av Dreyer, Sven Lennart Styrelsen ska bestå av 2 styrelseledamöter och 1 styrelsesuppleant.
Company purpose
Bolaget ska bedriva tjänster inom ekonomi, administration, juridik och företagsledning samt därmed förenlig verksamhet.
Address
Rörstrandsgatan 58
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −737 | −3 543 | −4 335 | −3 066 | −412 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −737 | −3 543 | −4 335 | −3 066 | −412 |
| Net financials | — | — | −1 | 7 | −1 |
| Profit before tax | −737 | −3 544 | −4 336 | −3 058 | −413 |
| Tax | 151 | 728 | 890 | 631 | −2 399 |
| Net profit | −586 | −2 816 | −3 446 | −2 427 | −2 812 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 555 | 1 162 | 2 142 | 2 817 | 2 472 |
| Equity | 25 | 25 | 25 | 363 | 25 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 530 | 1 137 | 2 117 | 2 454 | 2 447 |
| Total debt | 530 | 1 137 | 2 117 | 2 454 | 2 447 |
EBITDA margin
-41200000.0%
This company
15.8%
Market median
-260759594% vs market
20202024
Equity ratio
1.0%
This company
38.2%
Market median
-97% vs market
20202024
Return on equity
-11248.0%
This company
18.4%
Market median
-61230% vs market
20202024
Net profit margin
-281200000.0%
This company
8.1%
Market median
-3471605038% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
97.88×
This company
0.62×
Market median
-15687% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-02-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SL Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2021 | |
| Former (3) | ||
| Board of Directors | 2021 – 2024 | |
| Deputy Board Member | 2020 – 2021 | |
| Board of Directors | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CarryGenes Therapeutics AB
CarryGenes Management AB Board members of CarryGenes Management AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sven Lennart Dreyer | Chief Executive Officer | 0 companies |
| Amy Greene | Board of Directors | 0 companies |
| Rolf Andreas Sjödin | Deputy Board Member | 0 companies |
| Lars Olof Hellman | Board of Directors | 0 companies |
| Suite Gregory Betcheller | Chairman | 0 companies |